Daniel Gibson's most recent trade in Impinj Inc was a trade of 3,114 Restricted Stock Units done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Impinj Inc | Daniel Gibson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 3,114 | 3,114 | - | - | Restricted Stock Units | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 1,811 | 0 | - | - | Restricted Stock Units | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2025 | 1,811 | 19,896 (0%) | 0% | 0 | Common Stock | |
| Telesis Bio Inc | Daniel Gibson G. | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. | 27 Feb 2024 | 2,265 | 99,818 | - | 0.5 | 1,210 | Common Stock |
| Telesis Bio Inc | Daniel G. Gibson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 51,500 | 51,500 | - | - | Stock Option (right to buy) | |
| Telesis Bio Inc | Daniel G. Gibson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 6,400 | 106,218 | - | 0 | Common Stock | |
| Telesis Bio Inc | Daniel G. Gibson | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.53 per share. | 22 Jun 2023 | 656 | 105,562 | - | 0.5 | 346 | Common Stock |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 3,529 | 16,356 (0%) | 0% | 0 | Common Stock | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 3,529 | 0 | - | - | Restricted Stock Units | |
| Impinj Inc | Daniel Gibson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,729 | 1,729 | - | - | Restricted Stock Units | |
| Telesis Bio Inc | Daniel G. Gibson | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.83 per share. | 04 May 2023 | 1,190 | 102,083 | - | 2.8 | 3,363 | Common Stock |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 943 | 12,827 (0%) | 0% | 0 | Common Stock | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 870 | 11,884 (0%) | 0% | 0 | Common Stock | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 2,849 | 0 | - | - | Restricted Stock Units | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2021 | 2,849 | 11,014 (0%) | 0% | 0 | Common Stock | |
| Impinj Inc | Daniel Gibson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 870 | 870 | - | - | Restricted Stock Units | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 3,411 | 8,165 (0%) | 0% | 0 | Common Stock | |
| Impinj Inc | Daniel Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Oct 2020 | 3,411 | 0 | - | - | Restricted Stock Units |